| Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study LJ Pankhurst, C del Ojo Elias, AA Votintseva, TM Walker, K Cole, J Davies, ... The Lancet Respiratory Medicine 4 (1), 49-58, 2016 | 370 | 2016 |
| The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom K Schwarze, J Buchanan, JM Fermont, H Dreau, MW Tilley, JM Taylor, ... Genetics in Medicine 22 (1), 85-94, 2020 | 212 | 2020 |
| Biomarkers and clinical outcomes in COPD: a systematic review and meta-analysis JM Fermont, KL Masconi, MT Jensen, R Ferrari, VAP Di Lorenzo, ... Thorax 74 (5), 439-446, 2019 | 126 | 2019 |
| Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service A Hamblin, S Wordsworth, JM Fermont, S Page, K Kaur, C Camps, ... PLoS medicine 14 (2), e1002230, 2017 | 60 | 2017 |
| The EQ-5D-5L is a valid approach to measure health related quality of life in patients undergoing bariatric surgery JM Fermont, JM Blazeby, CA Rogers, S Wordsworth, ... PLoS One 12 (12), e0189190, 2017 | 34 | 2017 |
| Public stated preferences and predicted uptake for genome-based colorectal cancer screening CGM Groothuis-Oudshoorn, JM Fermont, JA van Til, MJ IJzerman BMC medical informatics and decision making 14, 1-10, 2014 | 29 | 2014 |
| Short physical performance battery as a practical tool to assess mortality risk in chronic obstructive pulmonary disease JM Fermont, D Mohan, M Fisk, CE Bolton, W Macnee, JR Cockcroft, ... Age and ageing 50 (3), 795-801, 2021 | 23 | 2021 |
| Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study JM Fermont, CE Bolton, M Fisk, D Mohan, W Macnee, JR Cockcroft, ... PloS one 15 (2), e0228940, 2020 | 19 | 2020 |
| Cardiovascular risk prediction using physical performance measures in COPD: results from a multicentre observational study JM Fermont, M Fisk, CE Bolton, W MacNee, JR Cockcroft, J Fuld, ... BMJ open 10 (12), e038360, 2020 | 11 | 2020 |
| Ranking medical innovations according to perceived health benefit JM Fermont, KHP Douw, H Vondeling, MJ IJzerman Health Policy and Technology 5 (2), 156-165, 2016 | 11 | 2016 |
| P1477: CHARACTERIZING SICKLE CELL DISEASE AND BURDEN OF ILLNESS IN THE UNITED STATES OF AMERICA: A RETROSPECTIVE ANALYSIS OF REAL-WORLD DATA ELJ Clay, J Paulose, C Rowe, M Tierney, Y Zhou, T Pattipaka, D Wormser, ... HemaSphere 6, 1359-1360, 2022 | | 2022 |
| Association of Hospitalization Due to Vaso-Occlusive Crisis with Subsequent Sickle Cell Disease-Related Organ Damage Hospitalization: Retrospective Analysis of 3-Year … MM Heeney, T Pattipaka, JM Fermont Blood 138, 2037, 2021 | | 2021 |
